No recent analyst price targets found for ATMP.
Latest News for ATMP
OS Therapies Granted EMA's Advanced Therapy Medicinal Product (ATMP) Designation for OST-HER2 in the Treatment of Pulmonary Recurrence in Resected Osteosarcoma
ATMP benefits include access to the Conditional Marketing Authorisation accelerated market access pathway in Europe, significantly reduced user fees for small and medium-sized enterprises (SMEs), tailored regulatory assessment via Committee for Advanced Therapies (CAT) and increased pricing power New York, New York--(Newsfile Corp. - March 25, 2026) - OS Therapies, Inc. (NYSE American: OSTX) ("OS Therapies" or "the…
🧮 Earnings Move Analyzer
Insider Trading
No insider trades found for ATMP.
Senate Trading
No Senate trades found for ATMP.
U.S. House Trading
No House trades found for ATMP.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.